DK3556869T3 - Sammensætninger og fremgangsmåder til sekventering af polynukleotider - Google Patents

Sammensætninger og fremgangsmåder til sekventering af polynukleotider Download PDF

Info

Publication number
DK3556869T3
DK3556869T3 DK19161148.2T DK19161148T DK3556869T3 DK 3556869 T3 DK3556869 T3 DK 3556869T3 DK 19161148 T DK19161148 T DK 19161148T DK 3556869 T3 DK3556869 T3 DK 3556869T3
Authority
DK
Denmark
Prior art keywords
polynucleotides
compositions
sequence
methods
Prior art date
Application number
DK19161148.2T
Other languages
English (en)
Inventor
Eric Stava
Jens H Gundlach
Jeffrey G Mandell
Kevin L Gunderson
Ian M Derrington
Hosein Himani
Original Assignee
Illumina Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Illumina Inc filed Critical Illumina Inc
Application granted granted Critical
Publication of DK3556869T3 publication Critical patent/DK3556869T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416Systems
    • G01N27/447Systems using electrophoresis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Electrochemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
DK19161148.2T 2013-11-26 2014-11-26 Sammensætninger og fremgangsmåder til sekventering af polynukleotider DK3556869T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361909316P 2013-11-26 2013-11-26
EP14830903.2A EP3074534B1 (en) 2013-11-26 2014-11-26 Methods for polynucleotide sequencing

Publications (1)

Publication Number Publication Date
DK3556869T3 true DK3556869T3 (da) 2023-10-02

Family

ID=52424089

Family Applications (2)

Application Number Title Priority Date Filing Date
DK14830903.2T DK3074534T3 (da) 2013-11-26 2014-11-26 Fremgangsmåder til polynukleotidsekventering
DK19161148.2T DK3556869T3 (da) 2013-11-26 2014-11-26 Sammensætninger og fremgangsmåder til sekventering af polynukleotider

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK14830903.2T DK3074534T3 (da) 2013-11-26 2014-11-26 Fremgangsmåder til polynukleotidsekventering

Country Status (12)

Country Link
US (5) US9689033B2 (da)
EP (3) EP4282983A3 (da)
JP (4) JP6800749B2 (da)
CN (2) CN105934522B (da)
AU (3) AU2014354726B2 (da)
CA (2) CA2926871C (da)
DK (2) DK3074534T3 (da)
ES (2) ES2958715T3 (da)
FI (1) FI3556869T3 (da)
LT (1) LT3074534T (da)
SI (1) SI3074534T1 (da)
WO (2) WO2015081178A1 (da)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0905140D0 (en) 2009-03-25 2009-05-06 Isis Innovation Method
JP6457811B2 (ja) 2011-09-23 2019-01-23 オックスフォード ナノポール テクノロジーズ リミテッド ポリマー単位を含むポリマーの解析
CN104321441B (zh) 2012-02-16 2016-10-19 牛津楠路珀尔科技有限公司 聚合物的测量的分析
CA2869546C (en) 2012-04-10 2020-07-21 Oxford Nanopore Technologies Limited Mutant lysenin pores
GB201222928D0 (en) 2012-12-19 2013-01-30 Oxford Nanopore Tech Ltd Analysis of a polynucleotide
GB201313477D0 (en) 2013-07-29 2013-09-11 Univ Leuven Kath Nanopore biosensors for detection of proteins and nucleic acids
US9689033B2 (en) * 2013-11-26 2017-06-27 Illumina, Inc. Compositions and methods for polynucleotide sequencing
WO2015110813A1 (en) 2014-01-22 2015-07-30 Oxford Nanopore Technologies Limited Method for attaching one or more polynucleotide binding proteins to a target polynucleotide
US10359395B2 (en) 2014-02-19 2019-07-23 University Of Washington Nanopore-based analysis of protein characteristics
EP3137490B1 (en) 2014-05-02 2021-01-27 Oxford Nanopore Technologies Limited Mutant pores
WO2016034591A2 (en) 2014-09-01 2016-03-10 Vib Vzw Mutant pores
EP4397972A3 (en) * 2014-10-16 2024-10-09 Oxford Nanopore Technologies PLC Alignment mapping estimation
WO2017027518A1 (en) * 2015-08-10 2017-02-16 Stratos Genomics, Inc. Single molecule nucleic acid sequencing with molecular sensor complexes
WO2017070549A1 (en) * 2015-10-21 2017-04-27 Genia Technologies, Inc. Use of fluoropolymers as a hydrophobic layer to support lipid bilayer formation for nanopore
AU2017225374B2 (en) 2016-03-02 2020-03-05 Oxford Nanopore Technologies Limited Mutant pore
CA3020203A1 (en) 2016-04-06 2017-10-12 Oxford Nanopore Technologies Limited Mutant pore
SG11201809016QA (en) 2016-04-14 2018-11-29 Lockheed Corp Selective interfacial mitigation of graphene defects
US10317392B2 (en) * 2016-06-23 2019-06-11 Roche Sequencing Solutions, Inc. Formation and calibration of nanopore sequencing cells
WO2018029108A1 (en) 2016-08-08 2018-02-15 F. Hoffmann-La Roche Ag Basecalling for stochastic sequencing processes
WO2018075785A1 (en) 2016-10-19 2018-04-26 Illumina, Inc. Methods for chemical ligation of nucleic acids
GB201707122D0 (en) 2017-05-04 2017-06-21 Oxford Nanopore Tech Ltd Pore
CN110914290A (zh) 2017-06-30 2020-03-24 弗拉芒区生物技术研究所 新颖蛋白孔
SG11201911977VA (en) 2017-09-15 2020-01-30 Illumina Inc Tuning and calibration features of a sequence-detection system
KR102620326B1 (ko) * 2017-09-15 2024-01-02 일루미나, 인코포레이티드 서열-검출 시스템
US10310959B2 (en) 2017-11-07 2019-06-04 Bank Of America Corporation Pre-deployment validation system using intelligent databases
ES2973770T3 (es) * 2018-06-21 2024-06-24 Hoffmann La Roche Puntos de unión de efecto túnel para secuenciación
EP3814529A1 (en) * 2018-06-26 2021-05-05 Electronic Biosciences Inc. Controlled nanopore translocation utilizing extremophilic replication proteins
CN112218877B (zh) 2018-08-27 2025-07-25 瑞泽恩制药公司 拉曼光谱在下游纯化中的应用
JP2020031557A (ja) * 2018-08-28 2020-03-05 株式会社日立ハイテクノロジーズ 生体分子分析装置
WO2020084705A1 (ja) * 2018-10-24 2020-04-30 株式会社日立ハイテク 生体ポリマ分析デバイス及びそれを用いた分析装置、並びに分析方法
GB201907244D0 (en) * 2019-05-22 2019-07-03 Oxford Nanopore Tech Ltd Method
WO2021056598A1 (zh) 2019-09-29 2021-04-01 北京齐碳科技有限公司 一种Mmup单体变体及其应用
IL293024A (en) * 2019-11-19 2022-07-01 Univ Groningen Artificial fertility, methods and uses thereof
NL2024579B1 (en) * 2019-12-24 2021-09-06 Univ Delft Tech Protein and peptide fingerprinting and sequencing by nanopore translocation of peptide-oligonucleotide complexes
CN114807317A (zh) * 2021-01-22 2022-07-29 上海羿鸣生物科技有限公司 一种优化的dna线性扩增方法及试剂盒
GB202107192D0 (en) * 2021-05-19 2021-06-30 Oxford Nanopore Tech Ltd Method
CN113322180B (zh) * 2021-05-31 2022-07-15 中国科学院物理研究所 基于纳米孔测序的力谱分析方法和分析装置
WO2023164728A2 (en) * 2022-02-28 2023-08-31 Rajant Health Incorporated Systems and methods for alignment-free variant calling
WO2024220969A2 (en) * 2023-04-21 2024-10-24 Arizona Board Of Regents On Behalf Of Arizona State University Novel transmembrane sensors and method of characterization for lysis-free detection of intracellular targets
CN119639558B (zh) * 2024-12-13 2025-09-26 杭州海兰时生物科技有限责任公司 一种用于单细胞测序的液滴融合系统

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4469863A (en) 1980-11-12 1984-09-04 Ts O Paul O P Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof
US5034506A (en) 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
US5235033A (en) 1985-03-15 1993-08-10 Anti-Gene Development Group Alpha-morpholino ribonucleoside derivatives and polymers thereof
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5216141A (en) 1988-06-06 1993-06-01 Benner Steven A Oligonucleotide analogs containing sulfur linkages
US5602240A (en) 1990-07-27 1997-02-11 Ciba Geigy Ag. Backbone modified oligonucleotide analogs
US5386023A (en) 1990-07-27 1995-01-31 Isis Pharmaceuticals Backbone modified oligonucleotide analogs and preparation thereof through reductive coupling
US5644048A (en) 1992-01-10 1997-07-01 Isis Pharmaceuticals, Inc. Process for preparing phosphorothioate oligonucleotides
US5637684A (en) 1994-02-23 1997-06-10 Isis Pharmaceuticals, Inc. Phosphoramidate and phosphorothioamidate oligomeric compounds
US5508179A (en) 1994-03-18 1996-04-16 Bio-Rad Laboratories, Inc. Use of deoxyribose nicotinamide adenine dinucleotide to enhance the specificity of NAD+ -dependent ligation reactions
US5795782A (en) * 1995-03-17 1998-08-18 President & Fellows Of Harvard College Characterization of individual polymer molecules based on monomer-interface interactions
AU5763000A (en) 1999-06-22 2001-01-09 President And Fellows Of Harvard College Molecular and atomic scale evaluation of biopolymers
ATE411397T1 (de) 2000-02-07 2008-10-15 Illumina Inc Nukleinsäure-nachweisverfahren mit universellem priming
US7582420B2 (en) 2001-07-12 2009-09-01 Illumina, Inc. Multiplex nucleic acid reactions
US6913884B2 (en) 2001-08-16 2005-07-05 Illumina, Inc. Compositions and methods for repetitive use of genomic DNA
US7955794B2 (en) 2000-09-21 2011-06-07 Illumina, Inc. Multiplex nucleic acid reactions
GB0505971D0 (en) 2005-03-23 2005-04-27 Isis Innovation Delivery of molecules to a lipid bilayer
EP2122344B8 (en) 2007-02-20 2019-08-21 Oxford Nanopore Technologies Limited Lipid bilayer sensor system
EP2307540B1 (en) * 2008-07-07 2017-04-19 Oxford Nanopore Technologies Limited Enzyme-pore constructs
ES2576114T3 (es) 2008-09-22 2016-07-05 University Of Washington Nanoporos MSP y procedimientos relacionados
GB0905140D0 (en) * 2009-03-25 2009-05-06 Isis Innovation Method
CN103392008B (zh) * 2010-09-07 2017-10-20 加利福尼亚大学董事会 通过持续性酶以一个核苷酸的精度控制dna在纳米孔中的移动
JP2014521956A (ja) 2011-07-27 2014-08-28 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティー オブ イリノイ 生体分子を特徴付けるためのナノ細孔センサー
KR20140090633A (ko) 2011-10-21 2014-07-17 옥스포드 나노포어 테크놀로지즈 리미티드 포어 및 hel308 헬리카제를 사용하여 표적 폴리뉴클레오티드를 특성화하는 방법
EP2798084B1 (en) 2011-12-29 2017-04-19 Oxford Nanopore Technologies Limited Enzyme method
EP2798083B1 (en) 2011-12-29 2017-08-09 Oxford Nanopore Technologies Limited Method for characterising a polynucelotide by using a xpd helicase
JP5809572B2 (ja) 2012-01-30 2015-11-11 ルネサスエレクトロニクス株式会社 半導体装置
CA2869546C (en) 2012-04-10 2020-07-21 Oxford Nanopore Technologies Limited Mutant lysenin pores
GB2557509A (en) * 2012-06-08 2018-06-20 Pacific Biosciences California Inc Modified base detection with nanopore sequencing
JP6614972B2 (ja) * 2012-07-19 2019-12-04 オックスフォード ナノポール テクノロジーズ リミテッド 修飾ヘリカーゼ
US9689033B2 (en) * 2013-11-26 2017-06-27 Illumina, Inc. Compositions and methods for polynucleotide sequencing

Also Published As

Publication number Publication date
US11041196B2 (en) 2021-06-22
EP4282983A2 (en) 2023-11-29
US20170268055A1 (en) 2017-09-21
JP6800749B2 (ja) 2020-12-23
AU2022231786A1 (en) 2022-10-13
CN105934522A (zh) 2016-09-07
JP2025072503A (ja) 2025-05-09
WO2015081211A2 (en) 2015-06-04
US9689033B2 (en) 2017-06-27
CN113528632A (zh) 2021-10-22
LT3074534T (lt) 2019-08-26
FI3556869T3 (fi) 2023-09-28
US20240167085A1 (en) 2024-05-23
CA2926871A1 (en) 2015-06-04
US11879155B2 (en) 2024-01-23
US20150152495A1 (en) 2015-06-04
ES2958715T3 (es) 2024-02-13
WO2015081211A3 (en) 2015-08-06
EP3074534B1 (en) 2019-05-01
JP2023116553A (ja) 2023-08-22
US20200024657A1 (en) 2020-01-23
US10364462B2 (en) 2019-07-30
CN105934522B (zh) 2021-07-20
AU2020202489A1 (en) 2020-05-07
AU2020202489B2 (en) 2022-06-23
EP3556869A1 (en) 2019-10-23
CA3157586A1 (en) 2015-06-04
EP3074534A1 (en) 2016-10-05
JP2017503473A (ja) 2017-02-02
EP4282983A3 (en) 2024-02-28
DK3074534T3 (da) 2019-07-29
AU2014354726B2 (en) 2020-03-12
EP3556869B1 (en) 2023-08-02
US20210355534A1 (en) 2021-11-18
JP2021040646A (ja) 2021-03-18
WO2015081178A1 (en) 2015-06-04
ES2735015T3 (es) 2019-12-13
SI3074534T1 (sl) 2019-08-30
JP7349972B2 (ja) 2023-09-25
CA3157586C (en) 2026-02-03
AU2014354726A1 (en) 2016-06-02
CA2926871C (en) 2022-08-16
AU2022231786B2 (en) 2025-04-17

Similar Documents

Publication Publication Date Title
DK3556869T3 (da) Sammensætninger og fremgangsmåder til sekventering af polynukleotider
IL282401A (en) Complement component irna compositions and methods of use thereof
DK3008168T3 (da) Sc-celler og sammensætninger og fremgangsmåde til dannelse deraf
DK3611262T3 (da) Fremgangsmåder til sekvensering af immunrepertoire
DK2970456T3 (da) Fremgangsmåder og sammensætninger til levering af mrna-kodede antistoffer
DK2961831T3 (da) Sammensætninger og fremgangsmåder til immunterapi
DK3594348T3 (da) Kort c/ebp-alpha til aktivering af rna-sammensætninger og anvendelsesfremgangsmåder
DK3080274T3 (da) Fremgangsmåder og sammensætninger til genom-manipulation
DK2994533T3 (da) Fremgangsmåder og sammensætninger til behandling af cancer
DK3252160T3 (da) Systemer, fremgangsmåder og sammensætninger med crispr-cas-bestanddele til sekvensmanipulation
DK2978419T3 (da) Sammensætninger til forbedring af cellelevedygtighed og fremgangsmåder til anvendelse deraf
DK3144001T3 (da) Sammensætninger af selenoorganiske forbindelser og fremgangsmåder til anvendelse deraf
DK2972353T3 (da) Forbedrede fremgangsmåder til udførelse af multipleksanalyser
DK3071215T3 (da) Sammensætninger og fremgangsmåder til behandling af pulmonal hypertension
DK3007695T3 (da) Sammensætninger og fremgangsmåder til behandling af anæmi
DK3071046T3 (da) Fremgangsmåde til ekstraktion af ærteproteiner
DK2929031T5 (da) Pcsk9-irna-sammensætninger og fremgangsmåder til anvendelse deraf
DK3261721T3 (da) Anvendelse af pridopidin til forbedring af hukommelse
DK2924093T3 (da) Multicarboxylat-sammensætninger og fremgangsmåde til fremstilling af disse
DK3300610T3 (da) Fremgangsmåde til fraktionering af opløselige ærter
DK3394259T3 (da) Sammensætninger og fremgangsmåder til reducering af tau-ekspression
DK3484469T3 (da) Sammensætninger og fremgangsmåder til potentiering af antimikrober
DK3065771T3 (da) Fremgangsmåder og sammensætninger til vedvarende immunterapi
DK3363805T3 (da) Fremgangsmåder til syntese af sphingomyeliner og dihydrosphingomyeliner
DK3393655T3 (da) Fenfluramin-sammensætninger og fremgangsmåder til fremstilling af samme